A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions
Latest Information Update: 27 Feb 2017
At a glance
- Drugs JVS 100 (Primary)
- Indications Scars
- Focus Adverse reactions
- Sponsors SironRX Therapeutics
Most Recent Events
- 17 Oct 2014 New trial record